About Pharma Industry

BNET Pharma provides daily industry trends and news coverage with insights for managers and executives about major manufacturers of pharmaceuticals and medicine. In addition to detailed drug company profiles, we bring you industry analysis on new partnerships, drug patents and products, cost management, investments, pharmaceutical related lawsuits, and a host of other important business issues.

Andy Behrman Resorts to Spam in Fight vs. BMS and Abilify

By Jim Edwards | May 18, 2009

Professional patient Andy Behrman is trying to turn his 15 minutes of Wall Street Journal fame into gold. Shortly after the Journal published a story about how he decided to become a critic of Bristol-Myers Squibb and Abilify following the company’s decision to stop paying him, Behrman sent a rambling email to his “friends” and “3,000+ mental health support groups” asking them “to forward this e-mail to everyone you know.” The email is a long plug for Behrman’s new book.

But it is also a description of just how thin Behrman’s case against BMS seems to be. As BNET noted a few days ago, Behrman only began his crusade against BMS after the company refused to make him a millionaire. Now he is claiming that BMS is at the center of a shadowy conspiracy to prevent him from speaking. His email says:

I published an online article about the drug’s terrible side effects. I said it was the worst drug that I had ever been prescribed and that it had nearly killed me. Within twenty minutes of the article being posted on a website owned by the New York Times, the article came down. Turns out, BMS was a sponsor of the website.

I believe that BMS will go to almost any lengths to stop me and the publication of the book.

Folks, BMS can’t negotiate a simple patent challenge properly, let alone organize a Pelican Brief-style silencing of one of its former consultants. It’s hard to see how Behrman is being silenced if he has received a front-page profile in the WSJ just weeks after his non-disclosure agreement with BMS ran out. His email continues:

The sad reality is that the drug companies won’t tell you the truth about the side effects of their drugs …

This just isn’t true. The side effects of Abilify are right there on the drug’s web site. The very first warning is:

Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death.

Behrman has a website, of course, and a YouTube video that he wants us all to watch (more examples of BMS’s chilling ability to censor its critics?). But the one thing he doesn’t provide in his book-blurb spam is the URL to the “front page story about my experience.” And that, as BNET readers know, is because the story makes Behrman look like a self-involved money-grubber who only found his voice against BMS after the company declined to pay him $7.5 million to keep his mouth shut.

Read Behrman’s full email after the jump.

Email from Andy Behrman:

I URGE YOU TO TAKE 60 SECONDS TO FORWARD THIS E-MAIL TO EVERYONE WHO YOU KNOW WHOSE LIVES ARE AFFECTED BY “BIG PHARMA” EVERY DAY!  Dear Friends, Three years ago, after working as a spokesman for Abilify, a hugely profitable drug manufactured by Bristol Myers Squibb, I published an online article about the drug’s terrible side effects. I said it was the worst drug that I had ever been prescribed and that it had nearly killed me.  Within twenty minutes of the article being posted on a website owned by the New York Times, the article came down. Turns out, BMS was a sponsor of the website. Today I am preparing to sell a new book, Adventures in the Drug Trade, which details my nightmarish experience with Abilify, my treatment by Dr. Mark Frye, a former UCLA psychopharmacologist now at the Mayo Clinic and curiously no longer a medical consultant for BMS, and my experiences as a pusher of their not-so-wondrous wonder drug.

I believe that BMS will go to almost any lengths to stop me and the publication of the book. It’s time to hold drug makers like BMS accountable for their corrupt practices and harmful products.  Just as culpable, if not more so, are the licensed physicians that aid and abet them. Do no harm?  I don’t think so. Today, The Wall Street Journal published a front page story about my experience titled, “A Celebrity Patient’s Backing Turns Sour for Drug Company.”  I urge you to click here for an informative sixty second video: http://www.youtube.com/watch?v=9VzMZX4nBz8

This youtube link will give you more information about the dangers of Abilify.  And then forward the link to everyone you know.

The sad reality is that the drug companies won’t tell you the truth about the side effects of their drugs and for that matter, neither will your doctor.  Did you know that pharmaceutical companies actually send some of these doctors on an all-expense-paid ten-day Caribbean cruises just for “writing prescriptions?” I urge you to forward this e-mail to ten friends, family members and mental health care professionals, whose lives are affected by Big Pharma every day and who might be interested in hearing the truth. If you’re one of the 3,000+ mental health support groups around the country receiving this e-mail, I  urge you to pass this on to your entire mailing list - - everyone should see the youtube video about the dangers of Abilify:
http://www.youtube.com/watch?v=9VzMZX4nBz8

We can beat big Pharma and their lies - - and even save some lives in the process –  but it has to begin with everyone standing up and telling the truth to anyone who will listen.Thanks,  Andy Behrman

http://www.electroboy.com

Jim Edwards, a former managing editor of Adweek, has covered drug marketing at Brandweek for four years, and is a former Knight-Bagehot fellow at Columbia University's business and journalism schools. Follow him on Twitter or send him an email.

BNET User Analysis

Web Buzz:
  • BMS and Abilify Emerge Mostly Unbruised in Fight With Professional Patient Andy Behrman

    BNET Pharma - 193 days 18 hours 45 minutes ago

    Bristol-Myers Squibb’s non-disclosure agreement with professional bipolar disorder patient Andy Behrman expired in January (as BNET noted last December) and, as expected, Behrman has come out of his corner full of allegations about how awful BMS’s promotion of Abilify is. Except that many of Behrman’s punches seem to be landing on himself....

  • Anti-Abilify Ad

    Schwitzer - 189 days 19 hours 4 minutes ago

    Andy Behrman's story was in the WSJ last week (""A Celebrity Patient's Backing Turns Sour for Drug Company.") He's the former spokesman for Bristol-Myers Squibb and its psychiatric drug Abilify. Emphasis on "former" spokesman because now he's turned against the company and its product. Here's his video with the message, "Ask Your Doctor If...

  • BMS Braces for Tell-All Book by Abilify Whistleblower

    BNET Insight - 329 days 15 hours 52 minutes ago

    In January, Andy Behrman’s non-disclosure agreement with Bristol-Myers Squibb expires. This will leave Behrman free to market his new book, Adventures in the Drug Trade: I Was a Big Pharma Pusher. Behrman is best known as the author of Electroboy, the 2002 account of his years spent trying to treat his bipolar disorder with electroshock...

  • Quote of the week - and It's only Monday morning!

    PharmaGossip - 190 days 1 hour 49 minutes ago

    "When you marry the devil's daughter don't be surprised when your father-in-law comes to visit." Corey Nahman writes: A Celebrity Patient's Backing Turns Sour for Drug Company … wasn't the truth, he says now. Within weeks of taking Abilify, Mr. Behrman says he felt stiffness and agitation in his legs. He says Abilify clouded...

  • Bristol pays $400M for Abilify lifeline

    Fierce Pharma - 231 days 18 hours 7 minutes ago

    Few drugmakers are expected to have a year as tough as Bristol-Myers Squibb's 2012. Like the Mayan calendar, time would run out in 2012 on two of Bristol's blockbuster meds: Plavix and Abilify. And voila! Some $7.8 billion in sales threatened. Not anymore, though. Bristol has inked a deal to keep its partnership with Japan's Otsuka...

 
Reply to Story

BNET TalkbackShare your ideas and expertise on this topic

Subscribe to this discussion via Email or RSS

  •  
    1

    GinaPera

    05/18/09 | Report as spam

    RE: Andy Behrman Resorts to Spam in Fight vs. BMS and Abilify

    Good call, Jim. "Big Pharma and their lies," indeed.

    Oh boy, the pathology is glaringly blatant, for anyone who
    knows how to see it. Paranoia. Denial. Persecution
    complex. Narcissism. Delusions of grandeur. "Twisting
    History." The works. Just what the anti-psychiatry crowd
    needs to whip themselves up into a self-medicating fury.

    Bottom line: Behrman gives mental illness a bad name.
    Better to have given that $400K, $1K each, to 400 "normal"
    people with bi-polar disorder. That would help to put a
    human face -- many faces -- to the condition and decrease
    stigma. They would probably have done it for free, in fact.
    People are desperate in this country for mental healthcare
    treatment.

    If the Abilify was titrated correctly, perhaps a few of them
    might even have found it life-changing. As for the rest, well,
    the human body is a complex thing, with lots of variability
    among individuals; that's why plenty of choices are needed.

    As it is, this guy has just reinforced all the worst, and
    undoubtedly least commonly manifested, notions about bi-
    polar disorder. Bad judgment on BMS's part to choose him
    as a spokesperson, but non-existent moral compass on
    Behrman's part to lie at every turn. I question if he ever
    took the medication at all.

    Shameful stuff.

    Gina Pera, author

  •  
    2

    digiteye

    05/21/09 | Report as spam

    RE: Andy Behrman Resorts to Spam in Fight vs. BMS and Abilify

    Before I burst in crying for BMS and Abilify, it was a smart move of BMS not to pay this guy.
    After all he is a lunatic, right? He has been treated with Abilify, right? So he is a nutcase by default.
    Whatever he says is easy to wipe off by saying: "c'mon, this is a schizophrenic guy, he talks BS and that's just another symptom of his condition".
    So how is it? A lunatic says the drug is bad, so the drug is actually not bad - one may say. Or everyone. Or the superficial ones.

    Smart, right? We may witness the first example a whole new type of marketing strategy, "hype through the negative message told by the schizo" - making the crowd trust the product even more.

    At the end of the day BMS may even create a nice glory around Abilify - which has horrible side effects btw, just like the others. Maybe slightly different ones. But is has.

    I am not a lunatic, I am ex-BMS. Not to be mistaken with an ex-Abilify patient, alright?

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement
Click Here